19th May 2021 10:49
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 18 May 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,771,267 | 10.2600 GBP | 10.2000 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
274,293 | 10.2600 GBP | 10.2000 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Short Position | 8,894 4,699 836 6,338 61,443 4,921 5,197 3,625 3,462
155 4,700 400 1,015 612
478 320 36 1,253 722 162,423 2,084 323 31 3,013
7,473 76,380 57,724 150,000 740 3,700
1,280,260 | 10.2201 GBP 10.2261 GBP 10.2278 GBP 10.2300 GBP 10.2301 GBP 10.2302 GBP 10.2359 GBP 10.2396 GBP 10.2401 GBP
10.2192 GBP 10.2203 GBP 10.2275 GBP 10.2300 GBP 10.2592 GBP
10.2100 GBP 10.2199 GBP 10.2200 GBP 10.2236 GBP 10.2271 GBP 10.2300 GBP 10.2328 GBP 10.2333 GBP 10.2400 GBP 10.2474 GBP
10.2151 GBP 10.2183 GBP 10.2251 GBP 10.2261 GBP 10.2300 GBP 10.2335 GBP
10.2600 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 19 May 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L